Powered by Google TranslateTranslate
Original text
Rate this translation
Your feedback will be used to help improve Google Translate
Latest Press Releases
View all
TimeHeadline
18m agoSunrun Prices $584 million Securitization of Residential Solar and Storage Assets
19m agoMadison Air Schedules First Quarter 2026 Earnings Conference Call and Webcast
42m agoUltra Clean Announces Retirement of the Chief Financial Officer Sheri Savage
43m agoGridAI Technologies Corp. Announces Receipt of NASDAQ Notice Regarding Late Form 10-K Filing
43m agoRush Enterprises, Inc. Reports First Quarter 2026 Results, Announces $0.19 Per Share Dividend
Ani Pharmaceuticals Inc logo

Ani Pharmaceuticals Inc

About

Ani Pharmaceuticals Inc (NASDAQ:ANIP) — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 24 2026
ANI Pharmaceuticals to Discuss First Quarter 2026 Financial Results on May 8, 2026, at 8:00 a.m. ET
Apr 20 2026
ANI Pharmaceuticals Announces the FDA Approval and Launch of Pimozide Tablets with 180 Day CGT Exclusivity
Apr 13 2026
ANI Pharmaceuticals Announces the Launch of Carbamazepine Extended-Release Capsules
Apr 8 2026
ANI Pharmaceuticals Announces FDA Approval and Launch of Isosorbide Mononitrate Tablet
Apr 7 2026
ANI Pharmaceuticals Announces Publication of NEW DAY Clinical Trial Results in Ophthalmology

Financials

Revenue
$883.37 M
Market Cap
$1.67 B
P/E Ratio
22.35
EPS
3.32

Community Chat

Ask AI

6ix6ixAIEvents